This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| bacteria:t3e:xopab [2025/02/24 11:54] – [Biological function] rkoebnik | bacteria:t3e:xopab [2025/07/28 15:18] (current) – [Biological function] rkoebnik | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== The Type III Effector XopAB from // | ====== The Type III Effector XopAB from // | ||
| - | Author: [[https:// | + | Author: [[https:// |
| Class: XopAB\\ | Class: XopAB\\ | ||
| Line 17: | Line 17: | ||
| === (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
| - | TT3S-dependent translocation of XopAB has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al.//, 2009). | + | TT3S-dependent translocation of XopAB has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al.//, 2009). |
| === Regulation === | === Regulation === | ||
| Line 39: | Line 39: | ||
| Zhao S, Mo WL, Wu F, Tang W, Tang JL, Szurek B, Verdier V, Koebnik R, Feng JX (2013). Identification of non-TAL effectors in // | Zhao S, Mo WL, Wu F, Tang W, Tang JL, Szurek B, Verdier V, Koebnik R, Feng JX (2013). Identification of non-TAL effectors in // | ||
| + | |||
| + | ===== Acknowledgements ===== | ||
| + | |||
| + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||
| + | |||